NIHR Biomedical Research Centre: Manchester shared on LinkedIn:
“We are pleased to announce that cancer research, supported by NIHR BRC: Manchester, has been awarded an NIHR20 Impact Prize.
Professor Emma Davidson received the award on behalf of the ‘Team Womb’ collective who are based at Manchester University NHS Foundation Trust and The University of Manchester.
They were recognised for their influential research into the link between Lynch syndrome and womb cancer.
The awards celebrate researchers and teams who have made an extraordinary impact on health and care outcomes, transforming patient care across the UK and internationally.
Lynch syndrome is a genetic condition associated with cancers such as bowel cancer. For the first time, the researchers demonstrated that Lynch syndrome increases the risk of womb cancer.
The team’s research led to an update to NICE guidelines for womb cancer and the national roll out of a new testing programme for Lynch syndrome.
Crucially, if a woman is diagnosed with Lynch syndrome, her family members can get tested too. If people test positive, they can gain access to care to prevent them from getting cancers in the future, such as bowel cancer screening. This could save lives and allow people to make informed decisions about their health.
Read more: Manchester cancer research team awarded prestigious NIHR20 Impact Prize.”
To which Manchester Cancer Research Centre added:
“Congratulations to Professor Emma Davidson and the ‘Team Womb’ collective on receiving an NIHR20 Impact Prize.
Their research into the link between Lynch syndrome and womb cancer has helped shape national guidelines and improve access to testing for patients and families.
This important work is helping people understand inherited cancer risk earlier, access preventative care, and make informed decisions about their health.
Read more about the NIHR20 Impact Prize: Manchester cancer research team awarded prestigious NIHR20 Impact Prize.”
Other articles about NIHR on OncoDaily.
